C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
12/2001
12/13/2001	WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
12/13/2001	WO2001093849A2 Treatment of gastroesophageal reflux disease using piperidine derivatives
12/13/2001	WO2001068140A3 Opioid formulations
12/13/2001	WO2001044200A3 Selective neurokinin antagonists
12/13/2001	US20010051730 Glycoprotein antagonist, inhibitor of blood platelet aggregation and fibrinogen binding
12/13/2001	US20010051729 Slurry of a sodium aluminum hydride, lithium or titanium containing additive and a Lewis base in solvent; non-pyrophoric; thermal stability
12/13/2001	US20010051728 Bromide salt formation and bromination of 1-methylpiperidin-4-one, reaction with 1,3,5-trimethoxybenzene, catalytic hydrogenation to cis compound; chemical intermediate in synthesis of flavopiridol
12/13/2001	US20010051633 E.g.,N-((4-amino-3-nitrophenoxy)ethyl)-1,2,3,4-tetrahydro -isoquinoline; stroke; antiischemic agents; CNS trauma, hyperglycemic agents; surgery; neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis
12/13/2001	US20010051626 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
12/13/2001	US20010051623 8-(Piperidin-4-yl- or piperazin-1-yl)-2-substituted-tetralin derivatives; selective effect at a subgroup of 5-hydroxytryptamine receptors, h5-HT1B receptors (previously 5-HT1D beta); antagonists; mood disorders, antianxiolytic
12/13/2001	DE10027611A1 New 2,4-disubstituted 5-sulfonyl-benzamides or analogs having LDL receptor inducing activity, useful for treating or preventing hyperlipidemia or arteriosclerosis
12/13/2001	CA2410227A1 Crystal modification of fexofenadine
12/12/2001	EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP0912499B1 Pesticides
12/12/2001	EP0765865B1 2-acylaminopropanol compound and medicinal composition
12/12/2001	EP0750610B1 Piperidyl-4-substituted thyrosine derivatives as scintigraphic imaging agents for the diagnosis of thrombosis
12/12/2001	EP0675924B1 Cyclic-substituted unsymmetrical cyanine dyes
12/12/2001	CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III
12/12/2001	CN1326440A Piperdine CCR-3 receptor antagonists
12/12/2001	CN1326439A Phenyl-substituted cyclic enaminones
12/11/2001	US6329397 Hydroxy pipecolate hydroxamic acid derivatives
12/11/2001	US6329396 Substituted benzylaminopiperidine compounds
12/11/2001	US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal
12/11/2001	US6329394 Medical use for tachykinin antagonists
12/11/2001	US6329385 Antiinflammatory agents, antiarthritic agents, viral diseases and gastrointestinal disorders
12/11/2001	US6329373 Metalloproteinase inhibitors
12/11/2001	CA2226292C Substituted benzolactam compounds as substance p antagonists
12/06/2001	WO2001092267A2 Dihydropyridine compounds for the inhibition of calcium-influx
12/06/2001	WO2001092228A2 Process for the synthesis of amine ethers from secondary amino oxides
12/06/2001	WO2001092227A1 Chemical compounds
12/06/2001	WO2001092226A1 Heterocyclic analgesic compounds and method of use thereof
12/06/2001	WO2001092198A1 Method for the production of esters of unsaturated carboxylic acids
12/06/2001	WO2001051474A3 Polypharmacophoric agents
12/06/2001	WO2001044167A8 Quaternary ammonium compounds and their use as anti-tussive agents
12/06/2001	WO2001040319A3 Inhibition of polymerization of unsaturated monomers
12/06/2001	WO2000046202A3 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetraalkylpyridines
12/06/2001	US20010049443 Reacting a ketoaldonic acid methyl ester of the sugar with the protected hydroxyl groups with an alkylamine or hydroxyamine acid salt with a tertiary amine to react with an acid generated in the reaction to produce oxime methyl ester
12/06/2001	US20010049370 4-Alkyl and 4-cycloalkyl derivatives of dihydropyridine NPY antagonists
12/06/2001	EP1144378A3 Process for the preparation of 1,2,3,6-tetrahydro-2,2,6,6-tetraalkylpyridines
12/06/2001	DE10027025A1 Clycinamide Clycinamide
12/06/2001	DE10027024A1 Carbaminsäureester Carbamic
12/06/2001	DE10026644A1 Verfahren zur Herstellung von Estern ungesättigter Carbonsäuren Process for the preparation of esters of unsaturated carboxylic acids
12/06/2001	CA2410655A1 Dihydropyridine compounds for the inhibition of calcium-influx
12/05/2001	EP1159261A2 Antizyme modulators and their use
12/05/2001	EP1159258A1 Amide compounds for the potentiation of cholinergic activity
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP1158980A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/05/2001	EP0994872B9 4-phenylpiperidine compounds
12/05/2001	EP0754176B1 Novel carbamates and ureas as modifiers of multi-drug resistance
12/05/2001	EP0669912B1 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists
12/05/2001	CN1325434A Washing and dry-cleaning method
12/05/2001	CN1325396A Aryl-{4-fluoro-4-[(2-pyridin-2-YL-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-HT1 receptor antagonists
12/04/2001	US6326496 Reduction with metal hydride
12/04/2001	US6326495 Heating a mixture of caprolactone and p-methoxybenzylamine; cyclization
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326382 Cholinesterase inhibitors; useful in enhancing memory in patients suffering from dementia and alzheimer's disease
12/04/2001	US6326381 Arylpiperidine and aryl-1,2,5,6-tetrahydropyidine amide derivates
12/04/2001	US6326372 Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists
12/04/2001	US6326369 Bicyclic quinone compounds, their production and use
12/04/2001	CA2229814C Peripherally active anti-hyperalgesic opiates
11/2001
11/29/2001	WO2001090113A1 Hydroxylamine esters as polymerization initiators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090082A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001089528A1 Thiourea derivatives of dihydropyridine npy antagonists
11/29/2001	WO2001089526A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	WO2001089498A2 USE OF (+)-α -(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL OR ITS PRODRUG IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND DOPAMINE INDUCED PSYCHOSIS
11/29/2001	WO2000059882A9 Anticancer calcium channel blockers
11/29/2001	US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers
11/29/2001	US20010047014 4-Benzyl-1-(2-(p-hydroxyphenoxy)ethyl)piperidine-3,4-diol; preparation from 1-(2-haloethoxy)-4-benzyloxybenzene and 4-benzylpiperidine-3,4-diol
11/29/2001	US20010047003 Anorexogenic agents to promote weight loss and treat eating disorders
11/29/2001	US20010047002 Squarate derivatives of dihydropyridine NPY antagonists
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	DE10123349A1 New N-sulfonylated pipecolic acid derivatives, are matrix metalloprotease inhibitors useful e.g. for treating rheumatism, tumor progression, arteriosclerosis or inflammatory bowel disease
11/29/2001	CA2408791A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1157989A1 Fluorides of 4-substituted piperidine derivatives
11/28/2001	EP1157987A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157001A1 Oxamic acids and derivatives as thyroid receptor ligands
11/28/2001	EP1156807A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/28/2001	EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001	EP0906281B1 Process for purifying sterically hindered 4-amino piperidines
11/28/2001	CN1324240A Treatment of disorders of the outer retina
11/28/2001	CN1075494C Fluoropiperidol quaternary ammonium salt derivative having cardiovascular activity
11/27/2001	US6323367 Reacting tertiary or secondary amine with hydrogen peroxide as an oxidant in presence of a recyclable heterogeneous layered double hydroxide exchanged with transition metal oxides as a catalyst in an organic solven, stirring, filtration
11/27/2001	US6323229 Compounds are useful psychotherapeutics and are potent agonists and/or antagonists of the serotonin 1a (5-ht 1a) and/or serotonin 1d (5-ht 1d) for treatment of hypertension, depression, generalized anxiety disorder
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds
11/27/2001	US6323220 Substituted pyridine or piperidine compounds
11/27/2001	US6323211 Alpha.-adrenergic receptor antagonist and at least one compound that elevates endogenous nitric oxide or endothelium-derived relaxing factor in vivo
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087830A2 Substituted thioacetamides

1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 380